GlassScriptPhysician profile
Julie Lam
NPI 1346639671
$30,602.49
in general payments reported to CMS, 2019-2025
28 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $959 · 2022: $2,355 · 2023: $1,517 · 2024: $15K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $9,909 · Travel and Lodging: $1,423 · Honoraria: $963 · Consulting Fee: $600 · Education: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,826.00 |
| Food and Beverage | $9,909.05 |
| Travel and Lodging | $1,422.53 |
| Honoraria | $962.50 |
| Consulting Fee | $600.00 |
| Education | $568.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $15,196.29 | 2021-2025 | Dupixent |
| Genzyme Corporation | $4,451.23 | 2021-2025 | |
| Abbvie INC. | $1,650.45 | 2021-2025 | |
| Janssen Biotech, INC. | $1,574.71 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Mayne Pharma Commercial LLC | $1,007.12 | 2021-2024 | |
| Arcutis Biotherapeutics, INC. | $937.15 | 2024-2025 | Zoryve |
| Pfizer INC. | $714.01 | 2021-2025 | |
| Leo Pharma INC. | $695.71 | 2021-2025 | Adbry, Anzupgo |
| Incyte Corporation | $635.64 | 2021-2025 | Opzelura, Opzelura |
| Sun Pharmaceutical Industries INC. | $548.03 | 2021-2025 | Absorica Ld, Winlevi |
| Lilly USA, LLC | $517.22 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Galderma Laboratories, L.P. | $497.34 | 2021-2025 | Nemluvio, Dysport |
| Ucb, INC. | $338.00 | 2021-2025 | Bimzelx, Cimzia |
| E.R. Squibb & Sons, L.L.C. | $309.27 | 2022-2025 | Sotyktu |
| Amgen INC. | $260.92 | 2023-2025 | Otezla, Otezla |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $224.87 | 2021-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Journey Medical Corporation | $212.87 | 2021-2025 | |
| Almirall LLC | $186.19 | 2021-2025 | Klisyri, Seysara |
| Revance Therapeutics, INC. | $131.80 | 2024-2025 | Daxi, Daxxify |
| Sanofi-Aventis U.S. LLC | $113.24 | 2021-2024 | |
| Strata Skin Sciences, INC. | $89.11 | 2022-2024 | Xtrac |
| Dermavant Sciences, INC. | $84.21 | 2023-2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $65.58 | 2021 | |
| Novartis Pharmaceuticals Corporation | $57.50 | 2024-2025 | |
| Organon LLC | $42.01 | 2025 | |
| Vyne Pharmaceuticals INC. | $23.83 | 2021 | |
| Merz North America, INC. | $19.34 | 2022 | |
| Genentech USA, INC. | $18.85 | 2023 | Xolair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.